Biotechnology – Page 8

Decheng Capital Seeks $700 Million for Fifth Life Sciences Fund Amidst VC Surge

11 months ago talkbio0Tagged Biotechnology, Capital, Decheng, Firm, Funds, venture

Decheng Capital, Life Sciences Fund, Venture Capital, Biotechnology, Investment Firm

ArriVent Expands ADC Portfolio with $615 Million Alphamab Acquisition

11 months ago talkbio0Tagged Acquisition (action), Alphamab, ArriVent, Biotechnology, financing characteristics, portfolio, therapeutic autologous dendritic cells

ArriVent, ADC portfolio, Alphamab, acquisition, biotech, biotechnology, financing

Merck & Co. Revives Ophthalmology Efforts with $3 Billion EyeBio Acquisition ###

12 months ago talkbio0Tagged Acquisition (action), Biotechnology, EyeBio, Merck & Co., Ophthalmology specialty, Trispecific Antibody

Merck & Co., EyeBio, Ophthalmology, Trispecific antibody, Restoret, Acquisition, Biotechnology, Pharmaceuticals

ExpressionEdits Secures $13M in Seed Funding to Revolutionize Protein Therapies with AI-Driven Intronization Technology

12 months ago talkbio0Tagged Biotechnology, ExpressionEdits, intronization, Plant seeds, protein expression, protein therapies, Technology

ExpressionEdits, Protein therapies, AI-driven intronization technology, Seed funding, Biotechnology, Protein expression

Repare Backer Amplitude Ventures Launches $192M Biotech Fund for Development and Growth

12 months ago talkbio0Tagged Amplitude, biotech fund, Biotechnology, development aspects, Growth, Investments, Repare, Ventures

Amplitude Ventures, biotech fund, Repare Therapeutics, development, growth, investment, biotechnology

Exscientia Streamlines Operations, Prioritizes AI-Driven Drug Discovery

12 months ago talkbio0Tagged AI-generated pipeline, Biotechnology, Drug Discovery, Drug Industry, Efficiency, Exscientia, operational, Staff

Exscientia, AI-generated pipeline, drug discovery, staff reduction, operational efficiency, biotechnology, pharmaceutical industry

Bicycle Therapeutics Gears Up for Future Milestones with $555 Million Capital Infusion

12 months ago talkbio0Tagged Bicycle, Biotechnology, Capital, Catalyst, Clinical Trials, Drug Development, Infusion procedures, investors, milestones

Bicycle Therapeutics, funding, catalysts, biotechnology, drug development, clinical trials, investors, capital infusion, milestones.

Evotec Discontinues Gene Therapy Operations, Shuts Down Austria Facility

12 months ago talkbio0Tagged Austria, Biotechnology, business operations, development aspects, Evotec, Facility (object), gene therapy, Reparative closure, research, strategic decision

Evotec, gene therapy, Austria, facility closure, strategic decision, business operations, research and development, biotechnology

AstraZeneca Acquires Option for SixPeaks: A Potential Breakthrough in Obesity Biotechnology

12 months ago talkbio0Tagged Acquisition (action), AstraZeneca, Biotechnology, Obesity, SixPeaks, Ventures, Versant

AstraZeneca, SixPeaks, Versant Ventures, obesity, biotechnology, acquisition, option, breakthrough.

Pheon Secures $120 Million in Series B Funding to Revolutionize Treatment for Challenging Cancers with Advanced Antibody-Drug Conjugates

12 months ago talkbio0Tagged Antibody-Drug, Antibody-Drug Conjugates, Biotechnology, Cancer Therapeutic Procedure, hard-to-treat cancers, healthcare innovation, Pheon, Series B

Pheon, Series B funding, $120 million, hard-to-treat cancers, antibody-drug conjugates (ADCs), cancer treatment, biotechnology, healthcare innovation.